Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00908_DB01151_nanopub.RAG0L4Z7wgYEBvOEXnItb_iAsx1egwAa6EElyLsnSAE6E#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00908_DB01151 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00908_DB01151 label "DDI between Quinidine and Desipramine - Additive QTc-prolonging effects may occur. Quinidine may also increase the serum concentration of the tricyclic antidepressant, desipramine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of desipramine if quinidine is initiated, discontinued or dose changed. Monitor for the development of torsades de pointes during concomitant therapy. [drugbank_resource:DB00908_DB01151]" assertion.
- drugbank_resource:DB00908_DB01151 identifier "drugbank_resource:DB00908_DB01151" assertion.
- drugbank_resource:DB00908_DB01151 title "DDI between Quinidine and Desipramine - Additive QTc-prolonging effects may occur. Quinidine may also increase the serum concentration of the tricyclic antidepressant, desipramine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of desipramine if quinidine is initiated, discontinued or dose changed. Monitor for the development of torsades de pointes during concomitant therapy." assertion.
- drugbank:DB00908 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00908_DB01151 assertion.
- drugbank:DB01151 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00908_DB01151 assertion.